Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON36378Not yet recruiting
Trial of unacylated ghrelin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Erasmus MC. Primary endpoint: Insulin levels. Planned start Dec 2010; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON36378.